{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:57:31Z","timestamp":1792425451298,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anndiagpath.2021.151795","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T02:01:23Z","timestamp":1626660083000},"page":"151795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Clinicopathologic and immunohistochemical study of breast angiosarcoma"],"prefix":"10.1016","volume":"54","author":[{"given":"Mingfei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bomeisl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Harbhajanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2021.151795_bb0005","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jso.24780","article-title":"Clinical outcomes in breast angiosarcoma patients: a rare tumor with unique challenges","volume":"116","author":"Gervais","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0010","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/1097-0142(19881115)62:10<2145::AID-CNCR2820621014>3.0.CO;2-O","article-title":"Mammary angiosarcoma. the prognostic significance of tumor differentiation","volume":"62","author":"Rosen","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clbc.2014.12.009","article-title":"Grade and prognosis in localized primary angiosarcoma","volume":"15","author":"Pandey","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3760\/cma.j.issn.0366-6999.20120993","article-title":"Stewart-treves syndrome angiosarcoma expresses phenotypes of both blood and lymphatic capillaries","volume":"126","author":"Stanczyk","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/PAS.0000000000001398","article-title":"Lymphatic-type \"Angiosarcoma\" with prominent lymphocytic infiltrate","volume":"44","author":"Martinez","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/modpathol.3880543","article-title":"Monoclonal antibody D2\u201340, a new marker of lymphatic endothelium, reacts with Kaposi&apos;s sarcoma and a subset of angiosarcomas","volume":"15","author":"Kahn","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pathol.2016.11.003","article-title":"Vascular tumours of the breast: a comprehensive review with focus on diagnostic challenges encountered in the core biopsy setting","volume":"49","author":"Ginter","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canrad.2015.01.001","article-title":"Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?","volume":"19","author":"Lae","year":"2015","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/modpathol.2013.163","article-title":"MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study","volume":"27","author":"Shon","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.pas.0000156664.04955.83","article-title":"Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases","volume":"29","author":"Brenn","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0b013e31815bf8fe","article-title":"Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma","volume":"32","author":"Patton","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ajcp\/102.6.757","article-title":"Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma","volume":"102","author":"Fineberg","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jclinpath-2019-205821","article-title":"Angiomatosis of the breast: a clinicopathological and immunophenotypical characterisation of seven cases","volume":"72","author":"Ginter","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1066896909350467","article-title":"Angiolipoma of the breast in a male: a case report and review of the literature","volume":"19","author":"Noel","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0899-7071(00)00165-0","article-title":"Angiolipoma of the breast with microcalcification. mammographic, sonographic, and histologic appearances","volume":"23","author":"Cheung","year":"1999","journal-title":"Clin Imaging"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1066896910385679","article-title":"Angiolipoma of the female breast: clinicomorphological correlation of 52 cases","volume":"19","author":"Kryvenko","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/DAD.0b013e3182685731","article-title":"Cellular angiolipoma: a clinicopathological and immunohistochemical study of 12 cases","volume":"35","author":"Sheng","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1524-4741.2002.08010.x","article-title":"Cellular angiolipoma of the breast: immunohistochemical study and review of the literature","volume":"8","author":"Kahng","year":"2002","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0095","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/tbj.13948","article-title":"Epithelioid hemangioma of breast mimicking malignancy: one trap during rapid frozen pathologic diagnosis","volume":"26","author":"Ren","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00000478-199206000-00003","article-title":"Hemangiomas of the breast with atypical histological features. further analysis of histological subtypes confirming their benign character","volume":"16","author":"Hoda","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/gcc.22912","article-title":"Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancer","volume":"60","author":"Hahn","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0110","doi-asserted-by":"crossref","first-page":"98ra82","DOI":"10.1126\/scitranslmed.3002409","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","author":"Tanas","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13000-019-0857-6","article-title":"A rare case of pseudomyogenic hemangioendothelioma (PHE)\/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature","volume":"14","author":"Ge","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0120","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1111\/jdv.14417","article-title":"Cutaneous pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma FOSB immunohistochemistry demonstrating the SERPINE1-FOSB fusion gene","volume":"31","author":"Alegria-Landa","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/DAD.0b013e318271295a","article-title":"Angiosarcoma: a tissue microarray study with diagnostic implications","volume":"35","author":"Rao","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0b013e3181fee872","article-title":"Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs","volume":"35","author":"Suchak","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jso.21497","article-title":"Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience","volume":"101","author":"Scow","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0140","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12282-015-0630-y","article-title":"Clinicopathological features of breast angiosarcoma","volume":"23","author":"Masai","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-006-9429-z","article-title":"Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature","volume":"105","author":"Luini","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.anndiagpath.2009.02.001","article-title":"Angiosarcoma of the breast: a clinicopathologic analysis of cases from the last 10 years","volume":"13","author":"Wang","year":"2009","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-0560.2011.01703.x","article-title":"Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: a report of five cases and review of the literature","volume":"38","author":"Shon","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0160","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1111\/pde.13664","article-title":"Angiosarcoma arising from congenital primary lymphedema","volume":"35","author":"Janssens","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0165","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/PAS.0b013e318176dbc7","article-title":"Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic","volume":"32","author":"Nascimento","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/tbj.12731","article-title":"Primary breast angiosarcoma: a retrospective study of 36 cases from a single Chinese medical institute with clinicopathologic and radiologic correlations","volume":"23","author":"Wang","year":"2017","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12885-017-3292-7","article-title":"Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study","volume":"17","author":"Yin","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0180","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000478-199806000-00005","article-title":"Angiosarcoma of soft tissue: a study of 80 cases","volume":"22","author":"Meis-Kindblom","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0185","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/PAS.0000000000000444","article-title":"Epithelioid angiosarcoma of the bladder: a series of 9 cases","volume":"39","author":"Matoso","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0190","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/PAS.0000000000001463","article-title":"Lymphatic-type angiosarcoma rich in plasma cells","volume":"44","author":"Chetty","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.humpath.2013.11.002","article-title":"Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites","volume":"45","author":"Ginter","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0200","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41379-020-0511-6","article-title":"Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis","volume":"33","author":"Beca","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0205","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/tbj.13439","article-title":"Management trends and outcomes of breast angiosarcoma: is breast conservation feasible?","volume":"25","author":"Hasan","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0210","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1245\/s10434-019-08085-1","article-title":"Treatment and prognosis of radiation-associated breast angiosarcoma in a Nationwide population","volume":"27","author":"Salminen","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0215","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/SLA.0000000000001753","article-title":"Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival","volume":"265","author":"Li","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1075-122X.2006.00280.x","article-title":"Primary angiosarcoma of the breast: do enlarged axillary nodes matter?","volume":"12","author":"Losanoff","year":"2006","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COC.0000000000000077","article-title":"Primary and radiation-induced breast angiosarcoma: clinicopathologic predictors of outcomes and the impact of adjuvant radiation therapy","volume":"39","author":"Ghareeb","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0230","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2008.20.4495","article-title":"Phase II study of sorafenib in patients with metastatic or recurrent sarcomas","volume":"27","author":"Maki","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1634\/theoncologist.2011-0237","article-title":"Sorafenib for patients with advanced angiosarcoma: a phase II trial from the French Sarcoma Group (GSF\/GETO)","volume":"17","author":"Ray-Coquard","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151795_bb0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/CCO.0b013e32833aaad4","article-title":"Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma\/solitary fibrous tumor","volume":"22","author":"Park","year":"2010","journal-title":"Curr Opin Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:49Z","timestamp":1761078829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":49,"alternative-id":["S1092913421000952"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151795","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic and immunohistochemical study of breast angiosarcoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151795"}}